Ann Partridge
#105,409
Most Influential Person Now
American medical oncologist
Ann Partridge's AcademicInfluence.com Rankings
Ann Partridgemedical Degrees
Medical
#1382
World Rank
#1714
Historical Rank
#372
USA Rank
Oncology
#82
World Rank
#86
Historical Rank
#17
USA Rank
Ann Partridgephilosophy Degrees
Philosophy
#5715
World Rank
#8599
Historical Rank
#1457
USA Rank
Logic
#2943
World Rank
#4022
Historical Rank
#653
USA Rank
Download Badge
Medical Philosophy
Ann Partridge's Degrees
- Doctorate Medicine University of California, San Francisco
Why Is Ann Partridge Influential?
(Suggest an Edit or Addition)According to Wikipedia, Ann Hart Partridge is an American medical oncologist. She is the founder and director of the Young and Strong Program for Young Women with Breast Cancer at the Susan F. Smith Center for Women's Cancers at the Dana–Farber Cancer Institute.
Ann Partridge's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 (2013) (2859)
- American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. (2006) (1829)
- Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. (2013) (1328)
- Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update. (2018) (758)
- Web-based survey of fertility issues in young women with breast cancer. (2004) (689)
- De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 (2018) (639)
- Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. (2003) (631)
- Adherence to therapy with oral antineoplastic agents. (2002) (572)
- Patient adherence and persistence with oral anticancer treatment (2009) (557)
- Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer. (2015) (483)
- Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: an American Society of Clinical Oncology guideline adaptation. (2014) (470)
- Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer. (2008) (460)
- Cancer and fertility preservation: international recommendations from an expert meeting (2016) (460)
- Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy. (2015) (424)
- Clinical activity of trastuzumab and vinorelbine in women with HER2-overexpressing metastatic breast cancer. (2001) (376)
- De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017. (2018) (353)
- Side effects of chemotherapy and combined chemohormonal therapy in women with early-stage breast cancer. (2001) (327)
- Biology of breast cancer in young women (2014) (276)
- Impact of a mixed strength and endurance exercise intervention on insulin levels in breast cancer survivors. (2008) (274)
- Prospective study of fertility concerns and preservation strategies in young women with breast cancer. (2014) (272)
- Subtype-Dependent Relationship Between Young Age at Diagnosis and Breast Cancer Survival. (2016) (245)
- Perceptions, Knowledge, and Satisfaction With Contralateral Prophylactic Mastectomy Among Young Women With Breast Cancer (2013) (243)
- Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer (2012) (243)
- Chemotherapy and targeted therapy for women with human epidermal growth factor receptor 2-negative (or unknown) advanced breast cancer: American Society of Clinical Oncology Clinical Practice Guideline. (2014) (225)
- Adjuvant chemotherapy in older women with early-stage breast cancer. (2009) (220)
- Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment Factors. (2015) (215)
- Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Premenopausal Patients With Early Breast Cancer: A Systematic Review and Meta-Analysis of Individual Patient-Level Data. (2018) (213)
- ESO-ESMO 3rd international consensus guidelines for breast cancer in young women (BCY3). (2017) (210)
- Second international consensus guidelines for breast cancer in young women (BCY2). (2014) (179)
- Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021 (2021) (175)
- Implications of Phytoestrogen Intake for Breast Cancer (2007) (167)
- Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study. (2008) (166)
- Seven-Year Follow-Up Analysis of Adjuvant Paclitaxel and Trastuzumab Trial for Node-Negative, Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer. (2019) (156)
- An approach to measuring the quality of breast cancer decisions. (2007) (154)
- Body image in recently diagnosed young women with early breast cancer (2013) (151)
- A Standard Set of Value-Based Patient-Centered Outcomes for Breast Cancer: The International Consortium for Health Outcomes Measurement (ICHOM) Initiative (2017) (149)
- Informing clinical trial participants about study results. (2002) (147)
- Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer. (2010) (147)
- Electronic self-report assessment for cancer and self-care support: results of a multicenter randomized trial. (2014) (147)
- The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS) (2019) (146)
- Association of Cell-Free DNA Tumor Fraction and Somatic Copy Number Alterations With Survival in Metastatic Triple-Negative Breast Cancer. (2018) (137)
- Age of menopause among women who remain premenopausal following treatment for early breast cancer: long-term results from International Breast Cancer Study Group Trials V and VI. (2007) (133)
- Risk-based health care, the cancer survivor, the oncologist, and the primary care physician. (2013) (124)
- First international consensus guidelines for breast cancer in young women (BCY1). (2014) (124)
- The effects of paclitaxel, dose density, and trastuzumab on treatment‐related amenorrhea in premenopausal women with breast cancer (2010) (123)
- Association between pharmaceutical involvement and outcomes in breast cancer clinical trials (2007) (115)
- Adherence and persistence with oral adjuvant chemotherapy in older women with early-stage breast cancer in CALGB 49907: adherence companion study 60104. (2010) (112)
- Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Clinical Practice Guideline Focused Update. (2018) (111)
- Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women's Sexual Health (2018) (111)
- Oral chemotherapy safety practices at US cancer centres: questionnaire survey (2007) (110)
- The effect of age on delay in diagnosis and stage of breast cancer. (2010) (107)
- Selection of Optimal Adjuvant Chemotherapy Regimens for Human Epidermal Growth Factor Receptor 2 (HER2) -Negative and Adjuvant Targeted Therapy for HER2-Positive Breast Cancers: An American Society of Clinical Oncology Guideline Adaptation of the Cancer Care Ontario Clinical Practice Guideline. (2016) (104)
- Decision making about surgery for early-stage breast cancer. (2012) (103)
- Fertility and adjuvant treatment in young women with breast cancer. (2007) (103)
- Preserving Fertility After Cancer (2005) (100)
- Supportive care after curative treatment for breast cancer (survivorship care): resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement. (2013) (97)
- Effect of age on breast cancer outcomes in women with human epidermal growth factor receptor 2-positive breast cancer: results from a herceptin adjuvant trial. (2013) (97)
- Treatment‐related amenorrhea and sexual functioning in young breast cancer survivors (2014) (93)
- Pregnancy after breast cancer: Are young patients willing to participate in clinical studies? (2015) (91)
- Genome-Wide Association Studies for Taxane-Induced Peripheral Neuropathy in ECOG-5103 and ECOG-1199 (2015) (91)
- Contributors to nonadherence and nonpersistence with endocrine therapy in breast cancer survivors recruited from an online research registry (2014) (90)
- Effect of the LIVESTRONG at the YMCA exercise program on physical activity, fitness, quality of life, and fatigue in cancer survivors (2017) (89)
- Offering participants results of a clinical trial: sharing results of a negative study (2005) (89)
- Pregnancy after breast cancer: if you wish, ma’am (2011) (87)
- Randomized trial of a physical activity intervention in women with metastatic breast cancer (2016) (86)
- Developing a service model that integrates palliative care throughout cancer care: the time is now. (2014) (83)
- Management of breast cancer in very young women. (2013) (83)
- Do patients participating in clinical trials want to know study results? (2003) (81)
- Breast cancer presentation and diagnostic delays in young women (2014) (81)
- Adjuvant Paclitaxel and Trastuzumab for Node-Negative, HER2-Positive Breast Cancer. (2023) (80)
- Ethics of mandatory research biopsy for correlative end points within clinical trials in oncology. (2010) (78)
- Anxiety and Depression in Young Women With Metastatic Breast Cancer: A Cross-Sectional Study. (2018) (77)
- Local Therapy Decision-Making and Contralateral Prophylactic Mastectomy in Young Women with Early-Stage Breast Cancer (2015) (77)
- Sentinel Lymph Node Biopsy in Pregnant Women with Breast Cancer (2014) (77)
- Surgical Upstaging Rates for Vacuum Assisted Biopsy Proven DCIS: Implications for Active Surveillance Trials (2017) (77)
- Management of breast cancer in very young women. (2013) (76)
- Medication errors involving oral chemotherapy (2010) (75)
- Fertility and menopausal outcomes in young breast cancer survivors. (2008) (75)
- Ovarian protection with gonadotropin-releasing hormone agonists during chemotherapy in cancer patients: From biological evidence to clinical application. (2019) (73)
- Letrozole Reduces Estrogen and Gonadotropin Exposure in Women With Breast Cancer Undergoing Ovarian Stimulation before Chemotherapy (2007) (72)
- Development and Validation of a Risk Prediction Model for Acute Kidney Injury After the First Course of Cisplatin. (2018) (70)
- Premature menopause in young breast cancer: effects on quality of life and treatment interventions. (2013) (70)
- BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer. (2016) (69)
- Sensitive Detection of Minimal Residual Disease in Patients Treated for Early-Stage Breast Cancer (2020) (69)
- Reproductive factors and risk of premenopausal breast cancer by age at diagnosis: Are there differences before and after age 40? (2013) (69)
- The BCY3/BCC 2017 survey on physicians' knowledge, attitudes and practice towards fertility and pregnancy-related issues in young breast cancer patients. (2018) (66)
- Oncology physician and nurse practices and attitudes regarding offering clinical trial results to study participants. (2004) (66)
- Efficacy of pegfilgrastim and darbepoetin alfa as hematopoietic support for dose-dense every-2-week adjuvant breast cancer chemotherapy. (2005) (66)
- Measuring decision quality: psychometric evaluation of a new instrument for breast cancer surgery (2012) (65)
- Supportive care during treatment for breast cancer: resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement. (2013) (64)
- Breast cancer survivors' perceptions of survivorship care options. (2012) (64)
- Time to diagnosis and breast cancer stage by race/ethnicity (2012) (63)
- Prognosis of pregnancy-associated breast cancer (2017) (63)
- Clinical cancer advances 2012: annual report on progress against cancer from the american society of clinical oncology. (2013) (62)
- Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care (2016) (62)
- Quality of life of older patients with early-stage breast cancer receiving adjuvant chemotherapy: a companion study to cancer and leukemia group B 49907. (2011) (62)
- Are Patients Making High-Quality Decisions about Breast Reconstruction after Mastectomy? [Outcomes Article] (2011) (60)
- Chemotherapy-related amenorrhea after adjuvant paclitaxel–trastuzumab (APT trial) (2015) (59)
- Effect of Eribulin With or Without Pembrolizumab on Progression-Free Survival for Patients With Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: A Randomized Clinical Trial. (2020) (59)
- American Society of Clinical Oncology endorsement of the cancer care Ontario practice guideline on adjuvant ovarian ablation in the treatment of premenopausal women with early-stage invasive breast cancer. (2011) (58)
- Final Analysis of the Prevention of Early Menopause Study (POEMS)/SWOG Intergroup S0230. (2018) (58)
- Menopausal symptoms and fertility concerns in premenopausal breast cancer survivors: a comparison to age- and gravidity-matched controls (2011) (57)
- Pregnancy-Associated Cancer: A U.S. Population-Based Study. (2019) (56)
- Augmentation of venlafaxine and selective serotonin reuptake inhibitors with zolpidem improves sleep and quality of life in breast cancer patients with hot flashes: a randomized, double-blind, placebo-controlled trial (2010) (56)
- Accrual of Older Patients With Breast Cancer to Alliance Systemic Therapy Trials Over Time: Protocol A151527. (2017) (55)
- Evidence-based approaches for the management of side-effects of adjuvant endocrine therapy in patients with breast cancer. (2021) (54)
- Young Women with Breast Cancer: A Focus Group Study of Unmet Needs. (2013) (54)
- Serum Detection of Nonadherence to Adjuvant Tamoxifen and Breast Cancer Recurrence Risk (2020) (54)
- Genetic associations with taxane-induced neuropathy by a genome-wide association study (GWAS) in E5103. (2011) (54)
- Model program to improve care for a unique cancer population: young women with breast cancer. (2012) (54)
- Evaluation and treatment of insomnia in adult cancer survivorship programs (2017) (54)
- Patient perspectives on breast cancer treatment plan and summary documents in community oncology care (2013) (53)
- Non-adherence to endocrine therapy for breast cancer. (2006) (53)
- Partner support and anxiety in young women with breast cancer (2015) (53)
- Outcomes and satisfaction after delivery of a breast cancer survivorship care plan: results of a multicenter trial. (2015) (52)
- Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer (2008) (52)
- Tolerability of and adherence to combination oral therapy with gefitinib and capecitabine in metastatic breast cancer (2009) (50)
- Long-term outcomes of children exposed to antineoplastic agents in utero. (2000) (49)
- Effect of Sustained Smoking Cessation Counseling and Provision of Medication vs Shorter-term Counseling and Medication Advice on Smoking Abstinence in Patients Recently Diagnosed With Cancer: A Randomized Clinical Trial. (2020) (49)
- Pregnancy After Breast Cancer in Patients With Germline BRCA Mutations. (2020) (49)
- Contralateral prophylactic mastectomy in women with breast cancer: trends, predictors, and areas for future research (2013) (48)
- Self-reported adherence to oral cancer therapy: relationships with symptom distress, depression, and personal characteristics (2015) (48)
- Cancer Treatment-Related Infertility: A Critical Review of the Evidence (2019) (48)
- Survival, Pathologic Response, and Genomics in CALGB 40601 (Alliance), a Neoadjuvant Phase III Trial of Paclitaxel-Trastuzumab With or Without Lapatinib in HER2-Positive Breast Cancer. (2020) (48)
- The electronic self report assessment and intervention for cancer: promoting patient verbal reporting of symptom and quality of life issues in a randomized controlled trial (2014) (48)
- Estimates of young breast cancer survivors at risk for infertility in the U.S. (2014) (47)
- High performance teamwork training and systems redesign in outpatient oncology (2013) (47)
- Doctor-patient communication about advance directives in metastatic breast cancer. (2009) (46)
- Update on fertility preservation in young women undergoing breast cancer and ovarian cancer therapy (2015) (46)
- Breast Cancer in Young Women: Rare Disease or Public Health Problem? (2015) (46)
- Lasting effects of cancer and its treatment on employment and finances in adolescent and young adult cancer survivors (2019) (46)
- Seven-year (yr) follow-up of adjuvant paclitaxel (T) and trastuzumab (H) (APT trial) for node-negative, HER2-positive breast cancer (BC). (2017) (45)
- Coping and psychological distress in young adults with advanced cancer. (2012) (44)
- Preoperative Psychosocial and Psychophysical Phenotypes as Predictors of Acute Pain Outcomes After Breast Surgery. (2019) (44)
- Prognostic Impact of the 21-Gene Recurrence Score Assay Among Young Women With Node-Negative and Node-Positive ER-Positive/HER2-Negative Breast Cancer (2019) (44)
- Biomarker prediction of chemotherapy-related amenorrhea in premenopausal women with breast cancer participating in E5103 (2014) (44)
- A phase II study of sagopilone (ZK 219477; ZK-EPO) in patients with breast cancer and brain metastases. (2011) (43)
- Open-label placebo reduces fatigue in cancer survivors: a randomized trial (2018) (43)
- Loss of RasGAP Tumor Suppressors Underlies the Aggressive Nature of Luminal B Breast Cancers. (2017) (43)
- Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial. (2019) (42)
- Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysis. (2019) (42)
- Long-term complications of adjuvant chemotherapy for early stage breast cancer. (2004) (41)
- Fertility (male and female) and menopause. (2012) (41)
- Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100 (2014) (41)
- Adjuvant Trastuzumab Emtansine Versus Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT): A Randomized Clinical Trial (2021) (41)
- Study protocol for Young & Strong: a cluster randomized design to increase attention to unique issues faced by young women with newly diagnosed breast cancer (2015) (41)
- Acupuncture for Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer Survivors: A Randomized Controlled Pilot Trial. (2019) (40)
- Association of Breast Cancer Surgery With Quality of Life and Psychosocial Well-being in Young Breast Cancer Survivors. (2020) (40)
- Is There a Role for Decision Aids in Advanced Breast Cancer? (2009) (39)
- Perceptions and management approaches of physicians who care for women with ductal carcinoma in situ. (2008) (38)
- The international collaboration of active surveillance trials for low-risk DCIS (LORIS, LORD, COMET, LORETTA). (2019) (37)
- Impact of race, ethnicity, and BMI on achievement of pathologic complete response following neoadjuvant chemotherapy for breast cancer: a pooled analysis of four prospective Alliance clinical trials (A151426) (2016) (37)
- Desired elements and timing of cancer survivorship care: one approach may not fit all. (2014) (37)
- Symptoms and Symptom Attribution Among Women on Endocrine Therapy for Breast Cancer. (2015) (37)
- Physical and psychological outcomes among women in a telephone-based exercise intervention during adjuvant therapy for early stage breast cancer. (2010) (36)
- Barriers to and facilitative processes of endocrine therapy adherence among women with breast cancer (2016) (36)
- On mammography--more agreement than disagreement. (2009) (36)
- CALGB (Alliance) 40603: Long-term outcomes (LTOs) after neoadjuvant chemotherapy (NACT) +/- carboplatin (Cb) and bevacizumab (Bev) in triple-negative breast cancer (TNBC). (2019) (34)
- Quality of life in long-term survivors of metastatic breast cancer. (2012) (33)
- Nonadherent behaviors among young women on adjuvant endocrine therapy for breast cancer (2019) (33)
- The Rodent Liver Undergoes Weaning-Induced Involution and Supports Breast Cancer Metastasis. (2017) (33)
- Cancer survivorship and the young breast cancer patient: addressing the important issues. (2013) (32)
- ABCDE steps to prevent heart disease in breast cancer survivors. (2014) (32)
- Pregnancy After Breast Cancer: A Systematic Review and Meta-Analysis (2021) (32)
- Standard chemotherapy (CMF or AC) versus capecitabine in early-stage breast cancer (BC) patients aged 65 and older: Results of CALGB/CTSU 49907 (2008) (32)
- Phase III trial (Prevention of Early Menopause Study [POEMS]-SWOG S0230) of LHRH analog during chemotherapy (CT) to reduce ovarian failure in early-stage, hormone receptor-negative breast cancer: An international Intergroup trial of SWOG, IBCSG, ECOG, and CALGB (Alliance). (2014) (32)
- Receipt of locoregional therapy among young women with breast cancer (2012) (32)
- Fertility Preservation in Patients With Breast Cancer: Necessity, Methods, and Safety. (2016) (32)
- Challenges in ductal carcinoma in situ risk communication and decision‐making (2012) (31)
- Fertility preservation: a vital survivorship issue for young women with breast cancer. (2008) (31)
- Acupuncture for Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer Survivors: A Randomized Controlled Pilot Trial. (2020) (30)
- Personalized medicine in breast cancer: tamoxifen, endoxifen, and CYP2D6 in clinical practice (2013) (29)
- Correction to: De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 (Annals of Oncology (2017) 28(8) (1700–1712), (S0923753419321817), (10.1093/annonc/mdx308)) (2017) (29)
- Psychosocial needs of young breast cancer survivors in Mexico City, Mexico (2018) (28)
- Association of Post-Diagnosis Cardiorespiratory Fitness with Cause-Specific Mortality in Cancer. (2020) (27)
- Quality of life and symptoms in male breast cancer survivors. (2013) (27)
- CALGB 40603 (Alliance): Long-Term Outcomes and Genomic Correlates of Response and Survival After Neoadjuvant Chemotherapy With or Without Carboplatin and Bevacizumab in Triple-Negative Breast Cancer (2022) (26)
- Surveillance Mammography in Older Patients With Breast Cancer—Can We Ever Stop?: A Review (2017) (26)
- Long-term risk perceptions of women with ductal carcinoma in situ. (2013) (26)
- Fertility concerns among breast cancer patients in Mexico. (2017) (26)
- Abstract GS1-05: TBCRC 033: A randomized phase II study of adjuvant trastuzumab emtansine (T-DM1) vs paclitaxel (T) in combination with trastuzumab (H) for stage I HER2-positive breast cancer (BC) (ATEMPT) (2020) (26)
- Perceptions, Attributions, and Emotions Toward Endocrine Therapy in Young Women with Breast Cancer. (2016) (25)
- Patient advocates' role in clinical trials (2012) (25)
- Emerging Data and Current Challenges for Young, Old, Obese, or Male Patients with Breast Cancer (2017) (24)
- Relationship between reproductive history, anthropometrics, lifestyle factors, and the likelihood of persistent chemotherapy-related amenorrhea in women with premenopausal breast cancer. (2012) (24)
- Interventions to enhance adherence to oral anti-neoplastic agents: A Scoping Review. (2020) (24)
- Variability in diagnostic threshold for comedo necrosis among breast pathologists: implications for patient eligibility for active surveillance trials of ductal carcinoma in situ (2019) (24)
- ALTERNATE: Neoadjuvant endocrine treatment (NET) approaches for clinical stage II or III estrogen receptor-positive HER2-negative breast cancer (ER+ HER2- BC) in postmenopausal (PM) women: Alliance A011106. (2020) (24)
- The impact of sharing results of a randomized breast cancer clinical trial with study participants (2009) (24)
- The definition of pregnancy-associated breast cancer is outdated and should no longer be used. (2021) (24)
- Mortality After Breast Cancer Among Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. (2019) (23)
- Epidemiology, Biology, Treatment, and Prevention of Ductal Carcinoma In Situ (DCIS) (2018) (23)
- Local–regional recurrence in women with small node-negative, HER2-positive breast cancer: results from a prospective multi-institutional study (the APT trial) (2019) (23)
- Knowledge, attitudes and practice of physicians towards fertility and pregnancy-related issues in youngBRCA-mutated breast cancer patients. (2019) (22)
- Contemporary multidisciplinary treatment of pregnancy-associated breast cancer (2013) (22)
- New Insights Into Nonadherence With Adjuvant Endocrine Therapy Among Young Women With Breast Cancer. (2015) (22)
- Ovarian suppression for prevention of premature menopause and infertility: empty promise or effective therapy? (2012) (22)
- Prediction of Persistent Pain Severity and Impact 12 Months After Breast Surgery Using Comprehensive Preoperative Assessment of Biopsychosocial Pain Modulators (2021) (21)
- Physical Activity Behaviors in Women with Newly Diagnosed Ductal Carcinoma-In-Situ (2008) (21)
- Clinical problem-solving. Breathless. (2012) (20)
- Molecular Phenotype of Breast Cancer According to Time Since Last Pregnancy in a Large Cohort of Young Women. (2015) (20)
- Sharing study results with trial participants: time for action. (2009) (20)
- Psychosexual functioning and body image following a diagnosis of ductal carcinoma in situ. (2013) (19)
- The unique reproductive concerns of young women with breast cancer. (2012) (19)
- The impact of young age at diagnosis (age <40 years) on prognosis varies by breast cancer subtype: A U.S. SEER database analysis (2021) (19)
- Fertility after breast cancer: questions abound. (2005) (19)
- Shared Medical Appointments in Cancer Survivorship Care: A Review of the Literature. (2015) (19)
- Randomized phase II study of eribulin mesylate (E) with or without pembrolizumab (P) for hormone receptor-positive (HR+) metastatic breast cancer (MBC). (2019) (19)
- Pneumocystis carinii pneumonia during dose-dense chemotherapy for breast cancer. (2006) (19)
- Employment trends in young women following a breast cancer diagnosis (2019) (19)
- Immediate breast reconstruction following mastectomy in pregnant women with breast cancer (2016) (18)
- Neoadjuvant endocrine therapy use in early stage breast cancer during the covid-19 pandemic (2021) (18)
- Exogenous reproductive hormone use in breast cancer survivors and previvors (2018) (18)
- Extended therapy with letrozole and ovarian suppression in premenopausal patients with breast cancer after tamoxifen. (2014) (18)
- Fatigue and physical activity in cancer survivors: A cross‐sectional population‐based study (2019) (18)
- Survival benefit needed to undergo chemotherapy: Patient and physician preferences (2017) (18)
- Informational needs and the quality of life of patients in their first year after metastatic breast cancer diagnosis. (2014) (17)
- The relationship between the belief in a genetic cause for breast cancer and bilateral mastectomy. (2015) (17)
- The role of socioeconomic status in adjustment after ductal carcinoma in situ (2010) (17)
- A pilot trial of brief group cognitive‐behavioral treatment for insomnia in an adult cancer survivorship program (2017) (16)
- Randomized trial of a clinic-based weight loss intervention in cancer survivors (2016) (16)
- Factors Associated with Nodal Pathologic Complete Response Among Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: Results of CALGB 40601 (HER2+) and 40603 (Triple-Negative) (Alliance) (2021) (16)
- Financial and work related impact of cancer in young adult (YA) survivors. (2016) (15)
- Pregnancy and breast cancer: epidemiology, treatment, and safety issues. (2005) (15)
- “I don't want to take chances.”: A qualitative exploration of surgical decision making in young breast cancer survivors (2018) (15)
- Measuring decision quality: psychometric evaluation of a new instrument for breast cancer chemotherapy (2014) (15)
- Oncology Physicians' Perspectives on Practices and Barriers to Fertility Preservation and the Feasibility of a Prospective Study of Pregnancy After Breast Cancer. (2017) (15)
- Evaluating the Utility of Baseline Cardiac Function Screening in Early-Stage Breast Cancer Treatment. (2016) (15)
- Helping breast cancer patients adhere to oral adjuvant hormonal therapy regimens (2007) (15)
- Who are the women who enrolled in the POSITIVE trial: A global study to support young hormone receptor positive breast cancer survivors desiring pregnancy (2021) (15)
- Male breast cancer networking and telephone support group: a model for supporting a unique population (2014) (15)
- Standards for follow-up care of patents with breast cancer. (2005) (15)
- Serial analysis of circulating tumor cells in metastatic breast cancer receiving first-line chemotherapy. (2020) (14)
- Breast Cancer in Young Women: Research Priorities. A Report of the Young Survival Coalition Research Think Tank Meeting. (2015) (14)
- Phase I study of JAK1/2 inhibitor ruxolitinib with weekly paclitaxel for the treatment of HER2-negative metastatic breast cancer (2021) (14)
- Unmet Needs in Clinical Research in Breast Cancer: Where Do We Need to Go? (2017) (14)
- Statins to mitigate cardiotoxicity in cancer patients treated with anthracyclines and/or trastuzumab: a systematic review and meta-analysis (2021) (14)
- Quality of life issues among women undergoing high-dose chemotherapy for breast cancer. (2001) (13)
- Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511) (2016) (13)
- A pilot videoconference group stress management program in cancer survivors: lessons learned. (2016) (13)
- Breast cancer in young women: a new color or a different shade of pink? (2008) (13)
- Higher Stage of Disease Is Associated With Bilateral Mastectomy Among Patients With Breast Cancer: A Population-Based Survey. (2016) (12)
- Adjuvant therapies for very young women with early stage breast cancer. (2011) (12)
- Pregnancy after breast cancer: Results from a prospective cohort of young women with breast cancer (2020) (12)
- Reduced Cardiorespiratory Fitness and Increased Cardiovascular Mortality After Prolonged Androgen Deprivation Therapy for Prostate Cancer (2020) (12)
- Research guidelines. (1995) (12)
- Changes in weight, physical and psychosocial patient-reported outcomes among obese women receiving treatment for early-stage breast cancer: A nationwide clinical study (2020) (12)
- Oncofertility: Fertile Ground for Conflict Between Patient Autonomy and Medical Values (2017) (12)
- A qualitative exploration of supports and unmet needs of diverse young women with breast cancer. (2015) (12)
- Chemotherapy in Premenopausal Breast Cancer Patients (2015) (12)
- Implementing a breast cancer registry and treatment plan/summary program in clinical practice: A pilot program (2013) (12)
- Predictors of increased risk for early treatment non-adherence to oral anti-estrogen therapies in early-stage breast cancer patients (2020) (11)
- The preference to receive chemotherapy and cancer-related outcomes in older adults with breast cancer CALGB 49907 (Alliance). (2018) (11)
- Posttraumatic stress in breast cancer survivors diagnosed at a young age (2020) (11)
- Trajectories of fear of cancer recurrence in young breast cancer survivors (2021) (11)
- The Patient’s Voice: Adherence, Symptoms, and Distress Related to Adjuvant Endocrine Therapy After Breast Cancer (2020) (11)
- Determinants of high tumor mutational burden (TMB) and mutational signatures in breast cancer. (2018) (11)
- ESMO Expert Consensus Statements on Cancer Survivorship: promoting high-quality survivorship care and research in Europe. (2022) (10)
- Identifying distinct trajectories of change in young breast cancer survivors' sexual functioning (2019) (10)
- Molecular correlates of response to eribulin and pembrolizumab in hormone receptor-positive metastatic breast cancer (2021) (10)
- Response to neoadjuvant chemotherapy and the 21-gene Breast Recurrence Score test in young women with estrogen receptor-positive early breast cancer (2020) (10)
- Randomized phase 2 trial of a coordinated breast cancer follow‐up care program (2016) (10)
- Breast Cancer Management Updates: Young and Older, Pregnant, or Male (2015) (9)
- Avoiding Peg-Filgrastim Prophylaxis During the Paclitaxel Portion of the Dose-Dense Doxorubicin-Cyclophosphamide and Paclitaxel Regimen: A Prospective Study (2020) (9)
- Development and Validation of a Predictive Model of Severe Fatigue After Breast Cancer Diagnosis: Toward a Personalized Framework in Survivorship Care (2022) (9)
- Lymphedema, musculoskeletal events and arm function in older patients receiving adjuvant chemotherapy for breast cancer (Alliance A171302) (2017) (9)
- Abstract P1-13-04: Enobosarm for the treatment of metastatic, estrogen and androgen receptor positive, breast cancer. Final results of the primary endpoint and current progression free survival (2015) (9)
- Chemotherapy-related amenorrhea (CRA) after adjuvant ado-trastuzumab emtansine (T-DM1) compared to paclitaxel in combination with trastuzumab (TH) (TBCRC033: ATEMPT Trial) (2021) (9)
- Association of Local Therapy With Quality-of-Life Outcomes in Young Women With Breast Cancer. (2021) (9)
- Comparison of operative to monitoring and endocrine therapy for low-risk DCIS (COMET study). (2018) (9)
- Cognitive Function of Older Patients Receiving Adjuvant Chemotherapy for Breast Cancer: A Pilot Prospective Longitudinal Study (2007) (9)
- Impact of Timing on Measurement of Decision Quality and Shared Decision Making: Longitudinal Cohort Study of Breast Cancer Patients (2019) (8)
- Body weight and return to work among survivors of early-stage breast cancer (2020) (8)
- Commentary: should cost and comparative value of treatments be considered in clinical practice guidelines? (2011) (8)
- Factors Affecting Surgical Decisions in Newly Diagnosed Young Women with Early-Stage Breast Cancer. (2019) (8)
- Genetic predictors of chemotherapy-related amenorrhea in women with breast cancer. (2019) (8)
- Clinical Significance of Circulating Tumor Cells in Hormone Receptor–positive Metastatic Breast Cancer Patients who Received Letrozole with or Without Bevacizumab (2020) (8)
- Association between adaptive immune signature and outcome in HER2-positive breast cancer treated with trastuzumab and lapatinib in the NCCTG-N9831 (Alliance) and NeoALTTO trials. (2018) (8)
- CALGB 60104: Adherence with adjuvant capecitabine among women age 65 and older with early stage breast cancer treated on CALGB 49907 (2008) (8)
- Long-Term Longitudinal Patterns of Patient-Reported Fatigue After Breast Cancer: A Group-Based Trajectory Analysis (2022) (8)
- Contralateral Prophylactic Mastectomy: An Opportunity for Shared Decision Making. (2014) (8)
- Clinicopathological features and BRCA1 and BRCA2 mutation status in a prospective cohort of young women with breast cancer (2021) (8)
- Looking back, moving forward: the evolution of cancer survivorship care. (2017) (8)
- Impact of fertility concerns on endocrine therapy decisions in young breast cancer survivors (2021) (8)
- Estimation of historical control rate for a single arm de-escalation study – Application to the POSITIVE trial (2020) (8)
- A randomized study to improve care for young women with breast cancer at community and academic medical oncology practices in the United States: The Young and Strong study (2019) (8)
- Surgical Treatment After Neoadjuvant Systemic Therapy in Young Women With Breast Cancer (2020) (7)
- Assessment of Ovarian Function in Phase 3 (Neo)adjuvant Breast Cancer Clinical Trials: A Systematic Evaluation. (2021) (7)
- Targeting Depressive Symptoms in Younger Breast Cancer Survivors: The Pathways to Wellness Randomized Controlled Trial of Mindfulness Meditation and Survivorship Education (2021) (7)
- Circulating Tumor DNA and Late Recurrence in High-Risk Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer (2022) (7)
- Clinical behavior and outcomes of breast cancer in young women with germline BRCA pathogenic variants (2021) (7)
- Contemporary management of breast cancer during pregnancy and subsequent lactation in a multicenter cohort of young women with breast cancer (2019) (7)
- Cancer survivorship care for young adults: a risk-stratified, multicenter randomized controlled trial to improve symptoms (2021) (7)
- Partners of young breast cancer survivors: a cross-sectional evaluation of psychosocial concerns, coping, and mental health (2020) (7)
- A prospective trial of treatment de-escalation following neoadjuvant paclitaxel/trastuzumab/pertuzumab in HER2-positive breast cancer (2022) (7)
- The Breast Cancer Weight Loss (BWEL) trial: Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early-stage breast cancer (Alliance A011401). (2018) (6)
- Abstract P2-13-02: Chemotherapy-related amenorrhea (CRA) after adjuvant trastuzumab emtansine (T-DM1) compared to paclitaxel in combination with trastuzumab (TH) (TBCRC033: ATEMPT trial) (2020) (6)
- Somatic and Germline Genomic Alterations in Very Young Women with Breast Cancer (2022) (6)
- Cancer Survivorship Care: An Opportunity to Revisit Cancer Genetics. (2016) (6)
- Moderate penetrance genes complicate genetic testing for breast cancer diagnosis: ATM, CHEK2, BARD1 and RAD51D (2022) (6)
- Chemotherapy-related amenorrhea in women with early breast cancer: The effect of paclitaxel or dose density. (2006) (6)
- Optimal Endocrine Therapy in Premenopausal Women: A Pragmatic Approach to Unanswered Questions. (2021) (6)
- The impact of fertility preservation on the timing of breast cancer treatment, recurrence, and survival (2021) (6)
- Breast cancer risk communication: challenges and future research directions: workshop report (United States) (2003) (6)
- Chemo- and Targeted Therapy for Women With Human Epidermal Growth Factor Receptor 2-Negative (or unknown) Advanced Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Summary. (2015) (6)
- Genomic-based predictive biomarkers to anti-HER2 therapies: A combined analysis of CALGB 40601 (Alliance) and PAMELA clinical trials. (2019) (6)
- Abstract P3-08-02: Breast cancer survivors’ outcomes and satisfaction following delivery of a survivorship care plan: Results of a multicenter trial (2013) (6)
- Follow-up care of breast cancer survivors. (2003) (6)
- Treatment-related amenorrhea among young women one year following diagnosis of early-stage breast cancer. (2015) (6)
- Breast cancer in young women: clinical decision-making in the face of uncertainty. (2009) (5)
- Cardiac outcomes of subjects on adjuvant trastuzumab emtansine vs paclitaxel in combination with trastuzumab for stage I HER2-positive breast cancer (ATEMPT) study (TBCRC033): a randomized controlled trial (2022) (5)
- Prevention of Premature Menopause and Preservation of Fertility in Young Cancer Survivors: Hopeful Though Modest Long-term Results. (2015) (5)
- Screening for Depression in Younger Breast Cancer Survivors: Outcomes From Use of the 9-item Patient Health Questionnaire (2021) (5)
- Coping strategies in young women with breast cancer. (2010) (5)
- Treatment of Breast Cancer During Pregnancy (2002) (5)
- Aggressive Subsets of Metastatic Triple Negative Breast Cancer. (2020) (5)
- Sexual Function Among Women in Midlife: Findings From the Nurses' Health Study II. (2019) (5)
- RESPONSE: Re: Adherence to Therapy With Oral Antineoplastic Agents (2002) (5)
- Preoperative systemic therapy in locoregional management of early breast cancer: highlights from the Kyoto Breast Cancer Consensus Conference (2012) (5)
- Abstract GS4-05: Neoadjuvant chemotherapy (NCT) response in postmenopausal women with clinical stage II or III estrogen receptor positive (ER+) and HER2 negative (HER2-) breast cancer (BC) resistant to endocrine therapy (ET) in the ALTERNATE trial (Alliance A011106) (2021) (5)
- Challenges to Standardizing the Care for Adult Cancer Survivors: Highlighting ASCO's Fatigue and Anxiety and Depression Guidelines. (2015) (5)
- Electronic self-report assessment for cancer: Results of a multisite randomized trial. (2012) (5)
- The ASCO Breast Cancer Registry pilot: Implementation of a multisite community practice registry and treatment plan/summary program. (2011) (5)
- Arm Morbidity After Local Therapy for Young Breast Cancer Patients (2021) (5)
- Evaluation of significant genome-wide association studies risk — SNPs in young breast cancer patients (2019) (5)
- POSITIVE (IBCSG 48-14/BIG 8-13/A221405): Evaluating outcomes after interrupting endocrine therapy (ET) for women with endocrine responsive (ER+) early breast cancer (BC) who desire pregnancy. (2018) (5)
- Safety of assisted reproductive techniques in young women harboring germline pathogenic variants in BRCA1/2 with a pregnancy after prior history of breast cancer (2021) (5)
- Prospective evaluation of the impact of stress, anxiety, and depression on household income among young women with early breast cancer from the Young and Strong trial (2020) (5)
- Anti-mullerian hormone as a serum biomarker for risk of chemotherapy-induced amenorrhea. (2020) (5)
- Delayed premature menopause following chemotherapy for early stage breast cancer: Long-term results from IBCSG Trial V (2005) (5)
- ABC trial (A011502): A randomized phase III double-blinded placebo-controlled trial of aspirin as adjuvant therapy breast cancer. (2018) (5)
- Effect of Unblinding on Participants' Perceptions of Risk and Confidence in a Large Double-Blind Clinical Trial of Chemotherapy for Breast Cancer. (2015) (5)
- Impact of Cancer History on Outcomes Among Hospitalized Patients with COVID‐19 (2021) (4)
- Breast cancer in younger women (2014) (4)
- Selection for Oncotype Dx testing among young women with early-stage ER+/HER2- breast cancer. (2018) (4)
- Treatment-related amenorrhea in a modern, prospective cohort study of young women with breast cancer (2021) (4)
- Adjuvant study of amcenestrant (SAR439859) versus tamoxifen for patients with hormone receptor-positive (HR+) early breast cancer (EBC), who have discontinued adjuvant aromatase inhibitor therapy due to treatment-related toxicity (AMEERA-6). (2022) (4)
- Local therapy outcomes and toxicity from the (anonymized for review) trial: A phase II randomized trial of adjuvant trastuzumab emtansine vs. paclitaxel in combination with trastuzumab in women with stage I HER2-positive breast cancer (2022) (4)
- Comparison of Equations To Estimate Glomerular Filtration Rate and Their Impact on Frequency of Cisplatin-associated Acute Kidney Injury. (2020) (4)
- Amenorrhea after lung cancer treatment (2019) (4)
- Self report assessment and support for cancer symptoms: Impact on hospital admissions and emergency department visits. (2013) (4)
- Treatment of primary resistant or relapsed multiple myeloma with high-dose chemoradiotherapy, hematopoietic stem cell rescue, and granulocyte-macrophage colony-stimulating factor. (2000) (4)
- Body weight changes and associated predictors in a prospective cohort of young breast cancer survivors (2022) (4)
- Biomarkers of amenorrhea and ovarian function in breast cancer survivors. (2012) (3)
- Standard chemotherapy versus capcitabine for older women with early stage breast cancer: An update of CALGB/CTSU/Alliance 49907. (2015) (3)
- Evaluating the effect of esthetically enhanced materials compared to standard materials on clinician response rates to a mailed survey (2013) (3)
- Estimation of historical control rate for a single arm de-escalation study: Application to the POSITIVE trial. (2018) (3)
- Personalizing treatment in early-stage breast cancer: The role of standard clinical factors and genomic information in adjuvant chemotherapy decision making. (2009) (3)
- Correction to: Statins to mitigate cardiotoxicity in cancer patients treated with anthracyclines and/or trastuzumab: a systematic review and meta‑analysis (2021) (3)
- Reply to 'The St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017: the point of view of an International Panel of Experts in Radiation Oncology' by Kirova et al. (2017) (3)
- Abstract PD3-05: The DAPHNE trial: A feasibility study of chemotherapy de-escalation based on response to neoadjuvant paclitaxel-HP (THP) in HER2-positive breast cancer (2021) (3)
- MotHER: A registry for women with breast cancer who received trastuzumab (T) with or without pertuzumab (P) during pregnancy or within 6 months prior to conception. (2013) (3)
- Symptom burden and employment status in breast cancer (BC) survivors. (2018) (3)
- Case‐control study of heart rate abnormalities across the breast cancer survivorship continuum (2018) (3)
- Physical Activity, Weight, and Outcomes in Patients Receiving Chemotherapy for Metastatic Breast Cancer (C40502/Alliance) (2021) (3)
- Mammography in Older Breast Cancer Survivors: Can We Ever Stop? (2017) (3)
- A telehealth intervention for symptom management, distress, and adherence to adjuvant endocrine therapy: A randomized controlled trial (2022) (3)
- Fertility Preservation in BRCA Carriers: Special Considerations (2017) (3)
- Contraceptive Use in Premenopausal Women With Early Breast Cancer (2022) (3)
- Psychosocial issues and quality of life of parenting partners of young women with breast cancer (2022) (3)
- Abstract PD10-02: Patient reported outcomes from the adjuvant trastuzumab emtansine (T-DM1) vs. paclitaxel + trastuzumab (TH) (ATEMPT) trial (TBCRC 033) (2020) (3)
- Surveillance imaging vs symptomatic recurrence detection and survival in stage II-III breast cancer (AFT-01). (2022) (3)
- Tumor phenotype and concordance in synchronous bilateral breast cancer in young women (2020) (3)
- Risk communication and decision-making in the prevention of invasive breast cancer. (2017) (3)
- Fertility outcomes in young women with breast cancer: A Web-based survey. (2004) (3)
- Prediction of Breast Cancer Treatment–Induced Fatigue by Machine Learning Using Genome-Wide Association Data (2020) (3)
- Reply to V. Turan et al. (2019) (3)
- Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer: final 10-year analysis of the open-label, single-arm, phase 2 APT trial. (2023) (2)
- Abstract GS2-10: Targeting depressive symptoms in younger breast cancer survivors: A randomized controlled trial of mindfulness meditation and survivorship education (2021) (2)
- Partners of young breast cancer survivors: A cross-sectional evaluation of psychosocial issues and mental health. (2017) (2)
- “Is it cancer or not?” A qualitative exploration of survivor concerns surrounding the diagnosis and treatment of ductal carcinoma in situ (2022) (2)
- Cyclophosphamide-free Adjuvant Chemotherapy for the Potential Prevention of Premature Ovarian Insufficiency and Infertility in Young Women with Breast Cancer. (2021) (2)
- The impact of an exercise intervention on body composition, fat distribution, and weight in breast cancer survivors. (2006) (2)
- A011801 (CompassHER2 RD): Postneoadjuvant T-DM1 + tucatinib/placebo in patients with residual HER2-positive invasive breast cancer. (2021) (2)
- The Breast Cancer Weight Loss trial (Alliance A011401): A description and evidence for the lifestyle intervention (2021) (2)
- Quality of Life Following Receipt of Adjuvant Chemotherapy With and Without Bevacizumab in Patients With Lymph Node–Positive and High-Risk Lymph Node–Negative Breast Cancer (2022) (2)
- Risk factors for heightened COVID‐19‐Related anxiety among breast cancer patients (2022) (2)
- Adaptive immune signature in HER2-positive breast cancer in NCCTG (Alliance) N9831 and NeoALTTO trials (2022) (2)
- Post-traumatic stress disorder in young breast cancer survivors. (2016) (2)
- Older‐Patient‐Specific Cancer Trials: A Pooled Analysis of 2,277 Patients (A151715) (2019) (2)
- Young, Empowered and Strong: A Web-Based Education and Supportive Care Intervention for Young Women With Breast Cancer Across the Care Continuum. (2021) (2)
- Breast cancer (BC) related fatigue: A longitudinal investigation of its prevalence, domains and correlates. (2018) (2)
- Fertility concerns in young women with breast cancer: Results from a prospective cohort study. (2011) (2)
- Pregnancy after breast cancer (2010) (2)
- Prognostic and Predictive Value of Immune-Related Gene Expression Signatures vs Tumor-Infiltrating Lymphocytes in Early-Stage ERBB2/HER2-Positive Breast Cancer (2023) (2)
- Prospective Study Testing a Simplified Paclitaxel Premedication Regimen in Patients with Early Breast Cancer (2021) (2)
- Mortality following breast cancer in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. (2018) (2)
- Abstract P5-11-04: A phase I/IIb study of palbociclib (PALBO) plus everolimus (EVE) and exemestane (EXE) in hormone-receptor positive (HR+)/HER2- metastatic breast cancer (MBC) after progression on a CDK4/6 inhibitor (CDK4/6i): Results of the phase II study (2020) (2)
- PD04-01: Predictors of Recovery of Ovarian Function during Aromatase Inhibitor (AI) Therapy. (2011) (2)
- Abstract PS12-17: Baseline characteristics of women enrolled in the POSITIVE trial (pregnancy outcome and safety of interrupting therapy for women with endocrine responsIVE breast cancer) (2021) (2)
- Abstract OT1-04-02: POSITIVE: A study evaluating pregnancy, disease outcome and safety of interrupting endocrine therapy for premenopausal women with endocrine responsive breast cancer who desire pregnancy (IBCSG 48-14/big 8-13) (2020) (2)
- Impact of physical activity on insulin levels in breast cancer survivors (2007) (2)
- Dynamics of Long-Term Patient-Reported Quality of Life and Health Behaviors After Adjuvant Breast Cancer Chemotherapy (2022) (2)
- Coordinated follow-up Breast Cancer Survivorship Care Program study. (2015) (2)
- Choosing mastectomy over lumpectomy: Factors associated with surgical decisions in young women with breast cancer. (2013) (2)
- REVIEW Adherence to Therapy With Oral Antineoplastic Agents (2002) (2)
- Impact of cancer on physical and mental activities of daily living in young adult (YA) survivors. (2019) (2)
- Pharmaceutical involvement in breast cancer clinical trials (2005) (2)
- Phase II trial of preoperative vinorelbine/trastuzumab (VH) or docetaxel/carboplatin/trastuzumab (TCH) in HER2-positive breast cancer with analysis of resistance mechanisms. (2010) (2)
- Predictive value of bother by side effects of treatment prior to protocol therapy for early treatment discontinuation in clinical trials. (2020) (2)
- Cancer Survivorship in Latin America: Current Status and Opportunities (2021) (2)
- Interactive medical case. Breathless. (2011) (2)
- Abstract P3-08-07: Survivorship care planning – When is intervention most effective? (2013) (2)
- Pregnancy after breast cancer: Results from a prospective cohort study. (2017) (2)
- Patient perspectives on a treatment plan and summary program in community oncology care. (2011) (2)
- Cardiac autonomic dysfunction in breast cancer survivors. (2017) (2)
- Age, race, BMI, and pathologic complete response following neoadjuvant chemotherapy: An analysis of four alliance clinical trials. (2015) (2)
- Abstract P5-12-13: What goes through your mind when you think about your medication? Thoughts about endocrine medication and treatment adherence (2016) (2)
- Phase III trial of LHRH analog during chemotherapy to reduce ovarian failure in early-stage, hormone receptor-negative breast cancer: An international Intergroup trial of SWOG, IBCSG, ECOG, and CALGB (2014) (2)
- Does biomarker information impact breast cancer patients’ preferences and physician recommendation for adjuvant chemotherapy? (2017) (2)
- Abstract P6-08-08: Postpartum breast cancer demonstrates increased liver and brain metastasis with a proposed role for postpartum involution (2015) (2)
- Abstract 2638: Sacituzumab Govitecan, combination with PARP inhibitor, Talazoparib, in metastatic triple-negative breast cancer (TNBC): Translational investigation (2022) (2)
- The utility of magnetic resonance imaging in early‐stage breast cancer survivors—An institutional experience and literature review (2020) (1)
- Asymptomatic distant recurrence detection and survival in early stage breast cancer: A nationally representative study. (2017) (1)
- Developing infrastructure to improve research and care for cancer survivors: A pilot study. (2016) (1)
- Is there a role for older-patient-specific cancer clinical trials? A pooled analysis of 2277 older patients in adjuvant breast cancer trials (Alliance A151715). (2018) (1)
- Developing a Novel Model to Improve Research and care for Cancer Survivors: a Feasibility Study (2019) (1)
- Receipt of locoregional therapy among young women with breast cancer. (2012) (1)
- Young women's preferences about adjuvant endocrine therapy for breast cancer. (2005) (1)
- Response to neoadjuvant chemotherapy and the 21-gene breast recurrence score in young women with estrogen receptor-positive early breast cancer. (2020) (1)
- Treatment of Breast Cancer in Young Adults. (2022) (1)
- Abstract GS3-09: Chances of pregnancy after breast cancer, reproductive and disease outcomes: A systematic review and meta-analysis (2021) (1)
- A phase II clinical trial of drug withdrawal in women with progressive breast cancer while on aromatase inhibitor therapy. (2011) (1)
- Pregnancy and Breast Cancer (2005) (1)
- A randomized phase III, double-blinded, placebo-controlled trial of aspirin as adjuvant therapy for breast cancer (A011502): The Aspirin after Breast Cancer (ABC) Trial (2022) (1)
- Sexual Pain and Cancer (2009) (1)
- Feasibility and Acceptability of a Web Site to Promote Survivorship Care in Survivors of Hodgkin Disease. (2017) (1)
- Comparing an operation to monitoring, with or without endocrine therapy (COMET), for low-risk ductal carcinoma in situ (DCIS). (2022) (1)
- Abstract P1-21-07: The Patient-reported Outcomes after Routine Treatment of Atypical Lesions (PORTAL) study: Pain, psychosocial wellbeing, and quality of life among women undergoing guideline concordant care for DCIS vs. active surveillance for in situ and atypical lesions (2020) (1)
- Clinical Benefit in the Treatment of Patients with Early Breast Cancer. (2019) (1)
- S38 Adjuvant therapies for the very young (2011) (1)
- Adjuvant endocrine therapy non-initiation and non-persistence in young women with early-stage breast cancer (2022) (1)
- Impact of cancer on employment and finances in young adult (YA) survivors. (2018) (1)
- Patterns and predictors of BRCA 1/2 testing in young breast cancer survivors. (2016) (1)
- Abstract PD5-06: Impact of an online ductal carcinomain situ(DCIS) decision support tool on awareness of treatment options and knowledge of breast cancer risks (2021) (1)
- Understanding the barriers to, and facilitators of, ovarian toxicity assessment in breast cancer clinical trials (2022) (1)
- Reproductive Health Issues for Young Women with Breast Cancer: Emerging Strategies for Difficult Situations (2019) (1)
- Assessment of ovarian function as an endpoint in breast cancer clinical trials: A systematic review. (2020) (1)
- Treatment of breast cancer in young women (2012) (1)
- Abstract GS4-09: Pregnancy Outcome and Safety of Interrupting Therapy for women with endocrine responsIVE breast cancer: Primary Results from the POSITIVE Trial (IBCSG 48-14/BIG 8-13) (2023) (1)
- The prevalence and predictors of adjuvant chemotherapy use among patients treated with neoadjuvant endocrine therapy (2022) (1)
- IN2 Breast cancer in young women: a rare disease or a significant public health problem? (2014) (1)
- Non-adherence behaviors among young women on adjuvant endocrine therapy for breast cancer. (2017) (1)
- Abstract SS2-05: Emerging from COVID-19 pandemic: Provider perspective on use of neoadjuvant endocrine therapy (NET) in early stage hormone receptor positive breast cancer (2021) (1)
- Abstract P6-08-03: Informational needs and psychosocial assessment of patients in their first year after metastatic breast cancer diagnosis (2012) (1)
- Pregnancy after cancer: Timing is everything (2018) (1)
- Correction: Evaluation of significant genome-wide association studies risk—SNPs in young breast cancer patients (2020) (1)
- Fertility preservation use and outcomes among young adult cancer survivors. (2018) (1)
- Alliance A011801 (compassHER2 RD): postneoadjuvant T-DM1 + tucatinib/placebo in patients with residual HER2-positive invasive breast cancer. (2021) (1)
- Early on-treatment transcriptional profiling as a tool for improving pathological response prediction in HER2-positive inflammatory breast cancer (2022) (1)
- Fatigue and health behaviors in cancer survivors: A cross-sectional population based study. (2017) (1)
- Outcomes after treatment of breast cancer during pregnancy including taxanes and/or granulocyte colony-stimulating factor use: findings from a multi-institutional retrospective analysis (2022) (1)
- Survival outcomes of premenopausal patients diagnosed with invasive lobular carcinoma. (2019) (1)
- Abstract P2-13-42: Effect of young age at diagnosis on clinical outcomes and efficacy of anti-HER2 targeted therapy in patients with HER2-positive early breast cancer: Results from the APHINITY trial (2022) (1)
- Abstract PD7-06: A randomized phase II trial of tamoxifen versus Z-endoxifen HCL in postmenopausal women with metastatic estrogen receptor positive, HER2 negative breast cancer (2020) (1)
- Abstract P2-13-02: Pathologic nodal staging and systemic therapy among patients with cT1-2N0 HER2+ breast cancer: A prospective single institution cohort analysis (2022) (1)
- Evaluating the addition of bevacizumab (Bev) to endocrine therapy as first-line treatment for hormone-receptor positive (HR+)/HER2-negative advanced breast cancer (ABC): Pooled-analysis from the LEA (GEICAM/2006-11_GBG51) and CALGB 40503 (Alliance) trials. (2017) (1)
- Abstract P4-10-01: Quality of life and symptom severity in the PALLAS randomized trial of palbociclib with adjuvant endocrine therapy in early breast cancer (AFT-05) (2022) (1)
- Hodgkin Lymphoma Survivor Wellness: Development of a Web-Based Intervention. (2020) (1)
- Ipsilateral invasive cancer risk after diagnosis with ductal carcinoma in situ (DCIS): Comparison of patients with and without index surgery. (2020) (1)
- P-166: Chemotherapy-related amenorrhea in premenopausal women with breast cancer: The effect of paclitaxel, dose density and trastuzumab (2006) (1)
- Germline TP53 pathogenic variants and breast cancer: A narrative review. (2023) (1)
- Clinical behavior and outcomes of breast cancer in young women with germline BRCA pathogenic variants (2021) (1)
- Morisky Medication Adherence Scale--Adapted (2017) (1)
- Abstract P4-07-02: Clinicopathological features and BRCA 1/2 status in a large prospective cohort of young women with breast cancer (2020) (1)
- Abstract P4-11-20: Attitudes and factors influencing contraception use over time in premenopausal women with early breast cancer in the prospective CANTO study (2022) (1)
- Endocrine therapy non-persistence in young women with early-stage breast cancer. (2017) (1)
- Treatment discontinuation, patient-reported toxicities and quality-of-life by age following trastuzumab emtansine or paclitaxel/trastuzumab (ATEMPT) (2022) (1)
- Comment on: Adherence to therapy with oral antineoplastic agents. Authors' reply (2002) (1)
- Biology of breast cancer in young women (2014) (0)
- Risk perceptions in localized breast cancer (BC). (2013) (0)
- Young and strong: A randomized study to improve care for young women with breast cancer. (2015) (0)
- Treatment-related amenorrhea in a modern, prospective cohort study of young women with breast cancer (2021) (0)
- ABC trial (A011502): A randomized phase III double-blinded placebo controlled trial of aspirin as adjuvant therapy breast cancer. (2019) (0)
- Fertility Counseling and Preservation in Breast Cancer (2020) (0)
- Abstract PD18-01: Adjuvant Trastuzumab Emtansine Versus Paclitaxel plus Trastuzumab for Stage I HER2+ Breast Cancer: 5-year results and correlative analyses from ATEMPT (TBCRC033) (2023) (0)
- Long-term symptom burden and orodental health of oropharyngeal cancer (OPC) survivors following treatment with chemoradiotherapy (CRT) or sequential therapy (ST). (2013) (0)
- Abstract PD18-02: Adjuvant Paclitaxel and Trastuzumab Trial (APT) for Node-Negative, Human Epidermal Growth Factor Receptor 2–Positive (HER2+) Breast Cancer: final 10-year analysis (2023) (0)
- Adjuvant Therapy Choices in Breast Cancer (2010) (0)
- Abstract P6-05-05: Patient-reported outcomes, perceptions, and knowledge about recurrence in women with high-risk hormone receptor-positive (HR+) breast cancer (BC) (2023) (0)
- Overweight, obesity and weight gain after breast cancer (BC): A prospective clinical study. (2018) (0)
- Neuropathy and health behaviors in cancer survivors treated with chemotherapy (CT). (2018) (0)
- Abstract PD13-10: Extended adjuvant endocrine therapy in a longitudinal cohort of young breast cancer survivors (2022) (0)
- Differential impact of endocrine therapy (ET) and chemotherapy (CT) on quality of life (QoL) of 4,262 breast cancer (BC) survivors: A prospective patient-reported outcomes (PRO) analysis. (2019) (0)
- Abstract GS6-01: Surgical treatment after neoadjuvant systemic therapy in young women with breast cancer: Results from a prospective cohort study (2019) (0)
- Clonal Hematopoiesis in Young Women Treated for Breast Cancer. (2023) (0)
- Abstract OT1-04-01: AMEERA-6: Phase 3 Study of Adjuvant Amcenestrant Versus Tamoxifen for Patients With Hormone Receptor-Positive Early Breast Cancer, Who Have Discontinued Adjuvant Aromatase Inhibitor Therapy Due to Treatment-related Toxicity (2023) (0)
- A randomized trial of a clinic-based weight loss intervention in cancer survivors. (2016) (0)
- Abstract PO-063: Impact of cancer history on outcomes among hospitalized COVID-19 patients: A case-control analysis (2020) (0)
- ASO Visual Abstract: Factors Associated with Nodal Pathologic Complete Response Among Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: Results of CALGB 40601 (HER2+) and 40603 (Triple-Negative) (Alliance) (2021) (0)
- Primary care providers’ comfort in caring for cancer survivors: Implications for risk‐stratified care (2022) (0)
- Abstract GS4-01: Impact of Breast Conservation Therapy on Local Recurrence in Patients with Multiple Ipsilateral Breast Cancer – Results from ACOSOG Z11102 (Alliance) (2023) (0)
- Fertility preferences, concerns, and preservation among young women with breast cancer who carry germline genetic pathogenic variants compared with non-carriers. (2022) (0)
- Genomics of HER2+ breast cancer in young women before and after exposure to chemotherapy (chemo) plus trastuzumab (H). (2019) (0)
- What I wish I had known: Young breast cancer survivors reflect on their experiences after breast cancer surgery. (2017) (0)
- Abstract P3-12-32: Long-term outcomes among young Saudi women with breast cancer (2022) (0)
- Body weight changes in young breast cancer survivors and associated predictors. (2019) (0)
- Local/Regional Recurrence Rates After Breast-Conserving Therapy in Patients Enrolled in Legacy Trials of the Alliance for Clinical Trials in Oncology (AFT-01) (2022) (0)
- Abstract P5-01-03: Ultrasensitive detection of minimal residual disease in patients treated for breast cancer (2020) (0)
- The influence of anatomic stage and receptor status on first recurrence for breast cancer within 5 years (AFT‐01) (2023) (0)
- Sexual functioning in young women with breast cancer. (2012) (0)
- Randomized trial of a physical activity intervention in patients with metastatic breast cancer. (2012) (0)
- Sentinel lymph node biopsy (SNB) in pregnancy-associated breast cancer (PABC). (2013) (0)
- Late Effects of Estrogen Deprivation in Breast Cancer (2017) (0)
- Impact of Anti-HER2 Therapy Alone and With Weekly Paclitaxel on the Ovarian Reserve of Young Women With HER2-Positive Breast Cancer. (2023) (0)
- Abstract P5-08-05: Conception and Pregnancy Among Young Breast Cancer Survivors (2023) (0)
- Reply to C. Twelves et Al. (2015) (0)
- Combination therapy with gefitinib and capecitabine in metastatic breast cancer (MBC): A phase I trial. (2016) (0)
- Early postoperative psychological distress as a mediator of subsequent persistent postsurgical pain outcomes among younger breast cancer patients (2022) (0)
- Optimizing endocrine therapy in premenopausal ER-positive breast cancer patients. (2009) (0)
- Impact of Age on Clinical Outcomes and Efficacy of Adjuvant Dual Anti-HER2 Targeted Therapy (2022) (0)
- Overcoming Obstacles in Transitions of Cancer Survivor Care. (2022) (0)
- Socioeconomic Factors and Adherence to Health Care Recommendations in Adolescent and Young Adult Cancer Survivors. (2023) (0)
- THE REGULATIONS FOR THE SAFE TRANSPORT OF RADIOACTIVE MATERIALS AS RECOMMENDED BY IAEA. II. THEIR APPLICATION, NATIONAL AND INTERNATIONAL, AND THE SOLUTION OF PROBLEMS RELEVANT TO SHIELDING OF SPECIAL INTEREST TO THE COMPETENT AUTHORITY. (1969) (0)
- Disparities in surveillance imaging after breast conserving surgery for primary DCIS. (2021) (0)
- Clinicopathologic Features, Treatment Patterns, and Disease Outcomes in a Modern, Prospective Cohort of Young Women Diagnosed with Ductal Carcinoma In Situ (2022) (0)
- Satisfaction with care and attention to salient concerns by race in a diverse national sample of young women with breast cancer. (2021) (0)
- Genetic testing in young women with breast cancer: Results from a web-based survey (2007) (0)
- Patient perspectives on testing for clonal hematopoiesis of indeterminate potential (2022) (0)
- Abstract PS9-08: The psychosocial impact of caregiving on partners of young women with breast cancer in treatment (2021) (0)
- TITLE: Sensitive detection of minimal residual disease in patients treated for early- 1 stage breast cancer 2 (2020) (0)
- Abstract PD5-06: Safety of assisted reproductive technologies (ART) following treatment completion in young women with germline BRCA pathogenic variants having a pregnancy after breast cancer (2022) (0)
- Behavioral treatment of insomnia in cancer survivors: Early results of a stepped-care trial. (2018) (0)
- Local Recurrence After Breast-Conserving Therapy in Patients With Multiple Ipsilateral Breast Cancer: Results From ACOSOG Z11102 (Alliance). (2023) (0)
- A new look at old problems: Ovarian function suppression in the real world (2021) (0)
- Abstract P5-08-06: Breastfeeding in Survivors of Early Breast Cancer (2023) (0)
- Abstract PR06: Racial/ethnic differences in breast cancer survival and mediating effects of tumor characteristics, sociodemographic, and treatment factors. (2012) (0)
- Clinicopathological features and BRCA1 and BRCA2 mutation status in a prospective cohort of young women with breast cancer (2021) (0)
- Clinical significance of circulating tumor cells (CTCs) in hormone receptor-positive (HR+) metastatic breast cancer (MBC) patients (pts) receiving letrozole (Let) or Let plus bevacizumab (Bev): CALGB 40503 (Alliance). (2019) (0)
- Increased Clinical Pain Locations and Pain Sensitivity in Women After Breast Cancer Surgery (2022) (0)
- Optimizing decision-making for DCIS: Facts over fear. (2020) (0)
- Abstract 494: Role of age, BMI, and tumor subtype in racial/ethnic disparities in breast cancer survival: A pooled analysis of four Alliance adjuvant clinical trials (2022) (0)
- Immediate tissue expander breast reconstruction following mastectomy in pregnancy-associated breast cancer. (2013) (0)
- Abstract A011: Effectiveness of an online decision support tool in communicating information about treatment options and related risks for ductal carcinoma in situ (DCIS) (2022) (0)
- PROGNOSTIC IMPORTANCE OF POOR CARDIORESPIRATORY FITNESS IN PATIENTS WITH CANCER REFERRED FOR EXERCISE TREADMILL TESTING (2018) (0)
- THE COMPETENT AUTHORITY: HOW IS HE COPING. (1969) (0)
- Improving biobehavioral health in younger breast cancer survivors: Pathways to Wellness trial secondary outcomes. (2022) (0)
- Reply to D. Serraino et al. (2014) (0)
- Abstract P2-13-17: Fertility concerns and treatment decision-making among young women with breast cancer (2020) (0)
- Ovarian function suppression, symptom burden, and quality of life in young women with breast cancer: A prospective study. (2015) (0)
- Preserving Fertility After Treatment for Breast Cancer (2015) (0)
- Employment trajectories of young women with breast cancer: an ongoing prospective cohort study in Italy and Switzerland (2022) (0)
- OP-JNCI210065 1274..1276 (2021) (0)
- Abstract P5-19-03: What are the barriers to assessment of ovarian toxicity in breast cancer clinical trials? (2022) (0)
- Risk Modification Strategies for Breast Cancer (2014) (0)
- Reply to L. Del Mastro and A. Prat. (2017) (0)
- Fertility Preferences and Practices Among Young Women With Breast Cancer: Germline Genetic Carriers Versus Noncarriers. (2022) (0)
- Erica T. WarnerRulla M. TamimiMelissa E. Hughes • Rebecca A. OttesenYu-Ning WongStephen B. EdgeRichard L. Theriault • Douglas W. BlayneyJoyce C. NilandEric P. WinerJane C. Weeks • (2012) (0)
- Evaluating the utility of baseline cardiac function assessment in early-stage breast cancer treatment. (2014) (0)
- BRITTLE FRACTURE PROBLEMS IN RELATION TO THICK WALLED PACKAGING. (1969) (0)
- IN19 Management of early menopause associated symptoms (2012) (0)
- Reply to E. Warner (2012) (0)
- Fertility issues among Mexican young breast cancer patients and impact of a dedicated program for preservation decisions. (2016) (0)
- Abstract PD5-05: Impact of anti-HER2 therapy alone and in association with weekly paclitaxel on the ovarian reserve of young women with HER2-positive early breast cancer: Biomarker analysis of the NeoALTTO trial (2022) (0)
- Accuracy of risk perceptions of women with ductal carcinoma in situ (2004) (0)
- Abstract P4-11-01: Development of a clinico-bio-behavioral model for cancer-related fatigue (CRF) incorporating inflammatory biomarkers and proteomic data (2022) (0)
- Understanding the psychosocial needs of young adults with cancer: Identifying targets for clinical intervention. (2011) (0)
- Physical activity (PA) and patterns of quality of life (QOL) after adjuvant chemotherapy (CT) for breast cancer (BC). (2018) (0)
- Influence of Aromatase Inhibitors on Pain and Pain Sensitivity in Women with Breast Cancer (2021) (0)
- Abstract PR009: Breast cancer (BC) risk reduction in young women with ductal carcinoma in situ (DCIS) (2022) (0)
- Selection of endpoints in breast cancer clinical trials: a qualitative study of key trial stakeholders. (2022) (0)
- Abstract P2-13-09: Trajectories of fear of cancer recurrence in young breast cancer survivors (2020) (0)
- The role of patient advocates in clinical trials: Perspectives from investigators and advocates in the Cancer and Leukemia Group B (CALGB). (2010) (0)
- Testing for clonal hematopoiesis of indeterminate potential in breast cancer survivors. (2021) (0)
- Impact of dental insurance coverage on presentation, long-term outcomes, and symptom burden in locally advanced head and neck cancer. (2019) (0)
- More Options for Premenopausal Women With Early-Stage Hormone-Sensitive Breast Cancer. (2015) (0)
- Surveillance Imaging after Primary Diagnosis of Ductal Carcinoma in Situ. (2023) (0)
- Reasons for Rise in CPM Explored (2014) (0)
- Quality of life and psychosocial distress in young women with advanced breast cancer. (2013) (0)
- Counterpoint: LHRH Agonists vs Ovarian Ablation for Suppression of Ovarian Function in Premenopausal Breast Cancer Patients. Ovarian Ablation Is a Viable Option for Select Patients. (2018) (0)
- HM32 Cognitive coping in young women with breast cancer (2014) (0)
- Impact of Young and Strong on physical activity in young breast cancer survivors. (2016) (0)
- Managing Side Effects of Estrogen Deprivation in Breast Cancer Patients (2017) (0)
- Clinical A ctivity o f T rastuzumab a nd V inorelbine i n Women W ith H ER2-Overexpress ing M etastatic B reast Cancer (2001) (0)
- Epidemiology (1963) (0)
- Implementation of a team training program in the treatment of breast cancer patients. (2012) (0)
- Repeated In Vitro Fertilization Cycles for Infertility (2017) (0)
- Repeated In Vitro Fertilization Cycles for Infertility (2017) (0)
- Cardiac outcomes of subjects on adjuvant trastuzumab emtansine vs paclitaxel in combination with trastuzumab for stage I HER2-positive breast cancer (ATEMPT) study (TBCRC033): a randomized controlled trial (2022) (0)
- Abstract P2-10-03: Decision-making surrounding adjuvant chemotherapy in young women with early stage breast cancer (2015) (0)
- Auricular Acupuncture During Chemotherapy Infusion in Breast Cancer Patients: A Feasibility Study. (2022) (0)
- An interview with Dr. Anthony Partridge by Dr. Michael Smith, past president of the Louisiana State Medical Society. (1978) (0)
- Comparing Two Treatment Approaches for Women with Ductal Carcinoma In Situ (DCIS) — The PORTAL Study (2021) (0)
- Abstract P5-14-06: Statins to mitigate cardiotoxicity in breast cancer patients treated with anthracyclines and/or trastuzumab: A systematic review and meta-analysis (2020) (0)
- Abstract PD6-1: BREAST-Q satisfaction and quality of life outcomes in young women undergoing mastectomy and reconstruction for breast cancer (2020) (0)
- Low-dose Tamoxifen For Radiation-Induced Breast Cancer Risk Reduction: A Phase IIB Randomized Placebo-Controlled Trial (2019) (0)
- Abstract P6-04-13: Centralized adequacy assessment of ductal carcinoma in situ samples for the COMET study (AFT-25) (2023) (0)
- BRCA1/BRCA2 (BRCA) testing in young women with breast cancer: Patterns, motivations, and implications for treatment decisions. (2014) (0)
- Abstract P4-12-01: Adherence with adjuvant endocrine therapy with or without Palbociclib in the PALLAS trial (2022) (0)
- Adaptive immune signature in HER2-positive breast cancer in NCCTG (Alliance) N9831 and NeoALTTO trials (2022) (0)
- Recognizing the Place of Trials With Treatment of Physician's Choice As the Control Arm Reply (2015) (0)
- Abstract P4-20-04: Young women with breast cancer in Mexico: A report of the pilot phase of the “Mujer Joven y Fuerte” prospective cohort (2017) (0)
- Abstract P2-01-02: Clinicopathological characteristics, treatment patterns and disease outcomes of germline BRCA1/2 carriers with early stage HER2-negative breast cancer and potential eligibility for adjuvant Olaparib (2023) (0)
- Physicians' knowledge, attitudes and practice towards fertility and pregnancy-related issues in BRCA-mutated breast cancer (BC) patients (pts): Results from the BCY3/BCC 2017 survey. (2018) (0)
- A prospective trial of treatment de-escalation following neoadjuvant paclitaxel/trastuzumab/pertuzumab in HER2-positive breast cancer (2022) (0)
- Abstract GS3-06: GS3-06 Palbociclib After CDK4/6i and Endocrine Therapy (PACE): A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab for Endocrine Pre-treated ER+/HER2- Metastatic Breast Cancer (2023) (0)
- Modern chemotherapy use among young women with early-stage ER+/HER2- breast cancer (2018) (0)
- Notifying Participants of Clinical Trial Results—Reply (2002) (0)
- Developing a Novel Model to Improve Research and care for Cancer Survivors: a Feasibility Study (2017) (0)
- Diagnostic and treatment delays in young women with breast cancer. (2019) (0)
- Integrating tobacco treatment into cancer care: A first snapshot of RCT findings. (2018) (0)
- Extended adjuvant endocrine therapy in a longitudinal cohort of young breast cancer survivors (2023) (0)
- PO18 BRCA1/BRCA2 (BRCA) testing in young women with breast cancer: patterns; motivations and implications for treatment decisions (2014) (0)
- Abstract SP114: Body Image and Sexual Health (2021) (0)
- Prevalence and predictors of decreased cardiorespiratory fitness among cancer patients. (2018) (0)
- Nonadherence t o A djuvant T amoxifen T herapy i n W omen W ith Primary B reast C ancer (2003) (0)
- Impact of overweight, obesity, and post-treatment weight changes on occupational reintegration of breast cancer (BC) survivors. (2019) (0)
- Avoiding peg-filgrastim (Peg-F) prophylaxis during the paclitaxel (T) portion of the dose-dense (DD) doxorubicin-cyclophosphamide (AC)-T regimen: A prospective study. (2019) (0)
- Abstract 1000: Associations of parity and body mass index with NanoString digital spatial protein profiling in early onset breast cancer (2023) (0)
- Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer. (2023) (0)
- Abstract P1-12-05: A qualitative exploration of self-developed and peer-recommended techniques used by women with breast cancer to improve sexual functioning during and after treatment (2019) (0)
- Abstract PD5-03: Ipsilateral invasive cancer risk after diagnosis with ductal carcinoma in situ in patients with and without index surgery: The effects of endocrine therapy and radiation treatment (2021) (0)
- Implementation of team training in outpatient breast oncology. (2012) (0)
- Impact of anti-HER2 therapy alone and in association with weekly paclitaxel on the ovarian reserve of young women with HER2-positive early breast cancer: Biomarker analysis of the NeoALTTO trial. (2022) (0)
- Abstract PD10-06: Clinical behavior and outcomes ofBRCA-mutated breast cancer in young patients according to type ofBRCAmutation and hormone receptor status: Results from an international cohort study (2021) (0)
- Abstract CT026: The effect of intrinsic subtype on inhibition of tumor growth by anastrozole vs. fulvestrant vs. the combination: Results from the Alliance neoadjuvant endocrine therapy (NET) ALTERNATE trial (2022) (0)
- Abstract PD9-03: Genomic analysis of the CALGB 40603 (Alliance) neoadjuvant trial in TNBC identifies immune features associated with pathological complete response and event-free survival (2021) (0)
- OR34 Sexual functioning in young women with breast cancer (2012) (0)
- Abstract P4-10-07: Genetic predictors of chemotherapy-related amenorrhea (2016) (0)
- Does biomarker information impact patients’ preferences for therapy? (2013) (0)
- Attitudes and Factors Influencing Contraception Use and Persistence in Premenopausal Women With Early Breast Cancer: Results From the Prospective CANTO Cohort Study (2022) (0)
- Correction to: Prediction of Persistent Pain Severity and Impact 12 Months After Breast Surgery Using Comprehensive Preoperative Assessment of Biopsychosocial Pain Modulators (2021) (0)
- Abstract PD12-08: Young, empowered & strong (YES): A web-based education and supportive care intervention for young women with breast cancer across the care continuum (2021) (0)
- Reply to M. Tanaka et al. (2021) (0)
- Ovarian Suppression for Women Younger Than 35 Years: New Data to Support Informed Decision Making. (2017) (0)
- The effects of a clinic‐based weight loss program on health‐related quality of life and weight maintenance in cancer survivors: A randomized controlled trial (2021) (0)
- Abstract PD2-08: Endocrine therapy non-persistence and recurrence in young women with early stage breast cancer (2021) (0)
- Accuracy of risk perceptions of women with ductal carcinoma in situ. (2004) (0)
- Estradiol (E2) levels in premenopausal women with hormone receptor-positive (HR+) breast cancer (BC) on ovarian function suppression (OFS) with gonadotropin-releasing hormone agonists (GnRHa). (2022) (0)
- Effects of an educational physical activity intervention in young women with newly diagnosed breast cancer: Findings from the Young and Strong Study. (2023) (0)
- Abstract P4-11-02: Prevalence and impact of fertility concerns in young women with breast cancer (2022) (0)
- Reproductive endocrinology: Triptorelin ovarian suppression during breast cancer chemotherapy (2011) (0)
- ASO Visual Abstract: Clinicopathologic Features, Treatment Patterns, and Disease Outcomes in a Modern, Prospective Cohort of Young Women Diagnosed with Ductal Carcinoma In Situ (2022) (0)
- Brief Report: Higher Stage of Disease is associated with Bilateral Mastectomy among Patients with Breast Cancer: A Population-Based Survey (2017) (0)
- Social determinants of health, genetic ancestry, and mortality in ECOG-ACRIN E5103. (2021) (0)
- Amenorrhea in lung cancer patients. (2017) (0)
- Cardiorespiratory fitness and cardiovascular mortality after prolonged androgen deprivation therapy for prostate cancer. (2019) (0)
- Abstract P5-15-07: Association of patient preference for adjuvant chemotherapy (chemo) at baseline (BL) with toxicity, mental health, function, quality of life (QoL) and survival in older women with early stage breast cancer (ESBC) [CALGB 49907 Alliance] (2015) (0)
- Association of cancer treatment with excess heart age among young breast cancer survivors. (2021) (0)
- ONCOLOGY NURSES ATTITUDES AND PRACTICES ABOUT INFORMING CLINICAL TRIALS PARTICIPANTS OF STUDY RESULTS (2011) (0)
- What is clinical benefit in the treatment of patients with early breast cancer? (2019) (0)
- Abstract P1-15-01: Withdrawn (2019) (0)
- Coping strategies and anxiety in young breast cancer survivors (2019) (0)
- Assessing the risk of severe post-treatment (tx) cancer-related fatigue (CRF) among breast cancer survivors (BCS) in the CANcer TOxicity (CANTO) cohort. (2021) (0)
- Study participants' perceptions of the process and impact of receiving results of N9831. (2006) (0)
- Nodal positivity and systemic therapy among patients with clinical T1-T2N0 human epidermal growth factor receptor-positive breast cancer: Results from two international cohorts. (2023) (0)
- Understanding surgical decision-making in newly diagnosed young women with early-stage breast cancer (2018) (0)
- Prediction of treatment (tx)-induced fatigue in breast cancer (BC) patients (pts) using machine learning on genome-wide association (GWAS) data in the prospective CANTO cohort. (2019) (0)
- Reproductive risk factors associated with breast cancer in young women by molecular subtype (2022) (0)
- Abstract OT-08-02: Comparing an operation to monitoring, with or without endocrine therapy (COMET): A prospective randomized trial for low-risk DCIS (AFT-25) (2021) (0)
- Care of the Cancer Survivor (2008) (0)
- Abstract CS1-2: Contralateral prophylactic mastectomy: Patient preferences and risk perceptions (2015) (0)
This paper list is powered by the following services:
Other Resources About Ann Partridge
What Schools Are Affiliated With Ann Partridge?
Ann Partridge is affiliated with the following schools:
